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ABSTRACT OF THE DISSERTATION 
Influence of Gender and Training Background on Effect of Exercise on Adiponectin 
 
by 
Pooja Pratap Mujumdar 
Doctor of Philosophy, Graduate Program in Pharmacology 
Loma Linda University, June 2011 
Dr. David Hessinger, Chairperson 
 
Adipose tissue secretes the adipokine, adiponectin (ADPN), which is insulin-
sensitizing, anti-inflammatory, and anti-atherogenic. Exercise training improves insulin 
sensitivity and lowers the risk of cardiovascular complications. As some of the metabolic 
effects of exercise training and ADPN overlap, exercise training has been proposed to 
increase ADPN. However, most single bout exercise, or short-term (3 months) and 
constant-effort (fixed session duration, fixed number of sessions/week, and fixed 
intensity) exercise protocols do not produce increases in ADPN in untrained and trained 
cohorts. Furthermore, most exercise studies were conducted on male-female mixed 
gender cohorts or male/female single gender cohorts. As a result, no direct comparison of 
male and female subjects pertaining to the effect of exercise on ADPN levels has been 
reported. Our governing hypothesis is that long-term aerobic exercise increases ADPN, 
and the increase in ADPN is influenced by gender and exercise training background. We 
tested two specific hypotheses using different cohorts of human volunteers. Hypothesis 1 
states that ADPN levels will increase significantly in previously untrained, middle-aged 
males and females in response to a long-term, progressive aerobic training protocol. 
Hypothesis 2 states that ADPN levels in multi-year trained female marathoners will 
increase significantly in response to a long-term, progressive aerobic training, but not in 
xii 
comparably trained males. We compared ADPN levels in trained marathoner males 
(n=10) and females (n=8) subjects and untrained males (n=9) and females (n=11) 
subjects in a 6-mo aerobic training intervention study. Fasting plasma samples were 
collected at the beginning and end of the 6-mo training period and analyzed. ADPN 
levels increased significantly in both trained and untrained females and untrained males, 
but non-significantly in trained males. Ours is the first study to compare changes in 
ADPN in mean age and BMI-matched male and female groups with two non-overlapping 
exercise training backgrounds in response to the same long-term, progressive aerobic 
training. The insight provided by the results of the two studies will help in understanding 
gender differences in ADPN.  
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CHAPTER ONE 
INTRODUCTION 
 
Obesity… The Much Talked about Issue! 
Obesity has currently become a worldwide public health issue in many developed and 
developing countries among people of all age groups. Increased caloric intake coupled 
with decreased physical exercise results in obesity. Obesity greatly increases the 
possibility of developing metabolic complications such as hypertension, atherosclerosis, 
dyslipidemia, and insulin resistance (IR) that later lead to type II diabetes (DM2). An 
estimated 24 million children and adult Americans have DM2; another 60 million people 
have the pre-diabetic condition of high blood sugar [1], increasing their risk for 
developing the disease. The American Diabetes Association estimates the cost of DM2 to 
be at least $174 billion a year as of 2007 [1]. 
 
 
What is Adiponectin and Why Should We Care for It? 
Adipose tissue, in addition to its function as a major energy store, is now known 
to function as an active endocrine tissue that secretes several hormone-like proteins 
termed adipokines. New adipokines are being discovered, but the current list of 
adipokines includes chemerin, interleukin-6 (IL-6), plasminogen activator inhibitor-1 
(PAI-1), retinol binding protein 4, tumor necrosis factor-alpha (TNF), visfatin, leptin, 
and adiponectin. Adipokines regulate satiety, lipid and carbohydrate metabolism, and 
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insulin sensitivity [2, 3]. Decreased insulin sensitivity [or insulin resistance (IR)] involves 
excessive insulin secretion in response to elevated blood glucose [3].  
Mature adipocytes from visceral fat release an anti-inflammatory, insulin-
sensitizing adipokine, adiponectin (ADPN) [4]. ADPN antagonizes the inflammatory 
effects of pro-inflammatory adipokines, IL-6 and TNF- and the levels of IL-6 and TNF-
 are inversely related to ADPN levels [5]. ADPN stimulates free fatty acid (FFA) 
oxidation in skeletal muscle [6] and ADPN levels positively correlate with circulating 
FFA concentration [7]. ADPN levels are significantly lower in overweight, obese, 
insulin-resistant, and diabetic individuals compared to lean or normal-weight individuals 
[6]. Females have higher basal levels of ADPN than males [8]. Non-Hispanic whites 
(Caucasians) have higher ADPN levels compared to other ethnic groups, such as non-
Hispanic blacks, Asians, and Hispanics [9]. The prevalence of DM2 is higher in all 
populations other than non-Hispanic whites [10].  
 
 
Aerobic and Resistance Exercise and Adiponectin, 
and The Possible Mechanism of Interaction 
 Aerobic exercise helps maintain healthy levels of body fat, decreases IR, 
improves DM2, and lowers the risk of developing cardiovascular complications [11]. 
Aerobic exercise has been at the forefront of life-style efforts to manage pre-diabetes and 
diabetes. The mechanism by which aerobic exercise brings about favorable changes in 
blood insulin and glucose levels is not yet known, but studies have noted the “anti-
inflammatory nature” of exercise [11].  
Metabolic effects of aerobic exercise include reduction in body weight and body 
fat, improved insulin sensitivity, improved cardiovascular health by improving plasma 
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lipoprotein profile, reducing blood pressure, and decreasing incidences or preventing the 
development of DM2 [11]. The reported metabolic effects of ADPN are: reduction of IR; 
increase FFA oxidation; decrease hepatic glucose production by inhibiting enzymes of 
gluconeogenesis; produce nitric oxide (NO) and improve endothelium-dependent 
vasodilation; and reduce in thrombus formation and platelet aggregation [12]. Because 
some of the metabolic effects of exercise training are similar to the effects of ADPN, 
aerobic exercise training has been proposed to increase ADPN [11]. Since the discovery 
of ADPN, studies have been conducted in human and rodent models to understand the 
connection between aerobic exercise training and ADPN levels [13-15]. Several human 
studies report that aerobic exercise increases [16-19] or does not increase [20-29] ADPN 
levels. Differences in study outcomes are mainly due to differences in –  
1. Cohort characteristics –  
 
(i) Metabolic profile of the cohort (e.g. trained subjects/athletes [24, 30-32], 
untrained normal-weight [22], untrained overweight [20, 26], untrained obese 
[16, 27-29, 33], untrained insulin-resistant, DM2 subjects [16-19, 21])  
(ii) Gender profile of the cohort (e.g. male-female combined [18, 19, 22, 23, 26, 
27, 33, 34] or single gender male [24, 25, 29, 35] or female [17, 20] cohort) 
2. Exercise intervention characteristics –  
 
(i) Duration of exercise training intervention (e.g. short-term (i.e. 3 mos) [20, 21, 
25, 27-29] or long-term (i.e. >3 mos) exercise studies [18, 19, 22-24, 26])  
(ii) Nature of exercise training protocol (e.g. constant effort [22, 23, 26, 27, 33, 34] 
or periodically increasing [progressive] protocol [18, 19, 35]) 
4 
Resistance/Strength training also has been shown to be helpful in managing of 
DM2 by maintaining muscle mass [36]. Intervention studies employing resistance 
training are fewer than aerobic exercise intervention studies and show increases [37-39] 
and no changes [40-42] in ADPN. Similar to aerobic exercise interventions the 
differences in the outcome of resistance training intervention also is due to  
1.  Cohort characteristics –  
 
(i) Cohort metabolic profiles – studies were conducted on overweight, obese, or 
DM2 subjects.   
(ii) Gender profile of the cohort – studies were conducted on male only or female 
only cohorts 
2.  Exercise intervention characteristics –  
(i)  Duration of exercise training intervention [e.g. short-term (i.e. 3 mos) [40-42] 
or long-term (i.e. >3 mos) [37-39]].  
(ii)  Intensity of exercise training protocol [e.g. low-medium intensity (i.e. 80% 
repetition maximum) [38, 40-42] or high intensity (i.e. >80% repetition 
maximum [37, 38]]. 
 
 
Anticipated Mechanism and Gaps in The Literature 
Some groups studying the effect of a long-term aerobic exercise on ADPN have 
proposed that increases in ADPN levels might be due to the indirect reduction in total 
body weight, mainly by reduction in body fat, or insulin resistance and not the direct 
effect of the exercise intervention. It has been suggested that weight losses of more than 
10% are necessary to detect significant increases in circulating ADPN [33]. Some 
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researchers made similar observation where the obese females lost more than 10% body 
weight through exercise intervention and showed a significant increase in ADPN [16, 
17]. However, Ring-Dimitriou et al. found an increase in ADPN with less than 10% 
decrease in body weight [18]. Some researchers found no increase in ADPN despite 
decreases in body weight [26-28]. In a cross-sectional study, ADPN levels were higher in 
physically active young adult females than in BMI- and age-matched sedentary females 
[43]. Reduction in total body weight may not be necessarily associated with an increase 
in ADPN.  
In general, an inverse correlation exists between ADPN levels and body fat [6]. A 
mean weight loss of 3% achieved by liposuction alone increased ADPN significantly in 
obese women [44], thus reduction in body fat may increase ADPN levels. However, the 
extent of body fat loss necessary to induce an increase in ADPN is not yet established. 
During a 2-year exercise intervention, changes in levels of ADPN and body fat were not 
inversely correlated [18] and a large (~44%) decrease in abdominal fat was not associated 
with an increase in ADPN [21]. Reduction in body fat may not be necessarily associated 
with an increase in ADPN.  
The possibility of a dose-response effect of exercise on ADPN was raised by 
studies where the intensity of aerobic exercise was varied [26]. Increasing levels of 
resistance training were found to increase ADPN levels [38]. Increased intensity, as well 
as increased duration of exercise increased ADPN in obese adolescent males [35].  
 
 
 
 
 
 
6 
Gender Differences in Adiponectin Levels  
 
Females, in general, exhibit higher ADPN levels than males [8]. This is primarily 
due to a significantly higher concentration of the high molecular weight isoform in 
females [8, 45]. Most long-term (>3 mos) exercise protocols studying the effect on 
ADPN levels were conducted on combined cohorts of untrained males and females [18, 
22, 23, 26, 34, 46] and only a few were conducted separately on male only [24, 35] or 
female only cohorts [16, 17]. Independent of the duration of the intervention and 
metabolic profile of the cohort, most aerobic exercise studies conducted solely with 
males failed to show significant increases in ADPN levels [24, 25, 29], whereas those 
with overweight and obese females showed increases in ADPN levels [16, 17, 19]. In a 
two-year, moderate exercise training intervention on obese males and females Ring-
Dimitriou et al. [18] reported that the females showed twice the mean net increase in 
ADPN compared to males at the end of 2-yr aerobic training. Long-term (>3 mos) 
resistance training studies have also observed greater increases in ADPN levels of 
females than males [37, 39]. Some researchers have raised a possibility that ADPN may 
change differently in the two sexes due to exercise alone [17] or due to differences in 
changes in body fat [46].  
 
 
Significance of the Study  
 
Exercise is at the forefront of DM2 treatment. Metabolic effects of exercise 
include reduction in body weight and body fat, improved insulin sensitivity, and 
improved cardiovascular health. Adiponectin (ADPN) is anti-inflammatory, insulin-
sensitizing, and anti-atherogenic. Because metabolic effects of exercise and ADPN 
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overlap, exercise is proposed to increase ADPN. Higher levels of ADPN are noted in 
athletes and centinarians. Females, in general, exhibit higher ADPN levels than males, 
but the effect of aerobic training on ADPN levels in males and females has not been 
compared. We studied the effect of long-term exercise training on ADPN in both 
untrained and multi-year trained, weight-stable subjects to understand if ADPN increases 
independently of body weight loss, exercise training conditioning, and gender. Our study 
findings will help fill the gaps in gender-based effectiveness of exercise with reference to 
ADPN levels.  
 
 
Novelty of the Study Design 
 
Females, in general, exhibit higher ADPN levels than males [8], but the effect of 
aerobic training on ADPN levels in males and females has not been compared. Multi-year 
trained male athletes have higher baseline ADPN levels than untrained controls [24, 31], 
but the effect of aerobic training on ADPN levels of trained and untrained individuals has 
not been compared. Several years of aerobic training reduces and stabilizes body weight, 
body fat, and resting plasma insulin levels [31]. ADPN levels are significantly and 
inversely correlated with body fat and resting plasma insulin levels [6]. Significant 
increases in ADPN in presence [16, 17] and absence [26-28] of significant weight loss 
have been reported, but changes in ADPN have not been compared in groups with and 
without weight loss through the same exercise intervention. Most exercise intervention 
studies did not control for changes in anthropometric measurements before interpreting 
the changes in ADPN as a result of exercise intervention [14]. Hence no relationship 
between weight reduction and changes in ADPN can be established. Our comprehensive 
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hypothesis connects the established findings and assists in filling in the gaps left from 
previous studies. 
This dissertation endeavors to answer following questions to fill in the present 
gaps in the literature -  
1. Does long-term aerobic training increase ADPN in healthy subjects? 
Most of the studies in the literature have been conducted on overweight, obese, insulin-
resistant, DM2 subjects. Even though these studies showed an increase in ADPN, studies 
conducted on healthy subjects showed no changes in ADPN.  
2. Is weight loss necessary for an increase in ADPN? 
The general opinion in the field is that a significant and more than 10% weight loss, 
brought about by caloric restriction or aerobic exercise intervention or liposuction-type 
weight reduction surgery procedures is essential for increases in ADPN levels. On the 
other hand, some studies employing progressive training protocol showed increased 
ADPN levels without significant weight loss. Many studies did not control for reductions 
in weight, body fat, waist circumference to correctly interpret if intervention-induced, 
specifically exercise intervention-induced increases in ADPN levels were due to 
intervention alone or due to reductions in anthropometric measurements.  
3. Are there gender differences in aerobic exercise-induced increases in ADPN? 
Most studies were conducted on mixed gender male/female cohorts or male only female 
only cohorts. Studies employing female only cohorts reported increases in ADPN while 
most studies employing male only cohorts reported no changes. Ring-Dimitriou et al. 
reported twice higher increase in ADPN in females compared to males [18]. No study 
compared males and females through same exercise intervention.  
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4. Are there training background-induced differences in increases in ADPN due 
to aerobic exercise training?  
Most studies were conducted on untrained subjects and only a few were conducted on 
trained subjects. But no study compared changes in ADPN levels in trained and untrained 
subjects undergoing same exercise training protocol. Do untrained subjects show higher 
increases in ADPN levels as they are not conditioned to exercise training? Do trained 
subjects show lesser increases in ADPN levels because they are conditioned to exercise 
training? Our comprehensive study strives to answer these questions.  
 
 
Hypothesis 
We hypothesize that long-term aerobic exercise increases total circulating 
adiponectin and that gender and exercise training background influence the exercise-
induced increase in adiponectin. Our governing hypothesis is based on several 
observations reported in the literature. It also makes several predictions that, to our 
knowledge, have not yet been tested. Our proposed study is designed to test the specific 
aspects of our working hypothesis. We will test two specific hypotheses using different 
cohorts of human volunteers.  
 
Hypothesis 1 
We hypothesize that ADPN levels will increase significantly in previously 
untrained males and females in response to long-term, progressive aerobic training. 
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Specific Aim 1 
To compare ADPN levels before and at the end of a long-term, progressive 
aerobic training regimen in middle-aged, untrained males and females. We will analyze 
ADPN levels in both males (M) and females (F) from the untrained group that have never 
trained for or participated in a full-distance (26.2 mile) marathon before. We will 
measure markers of insulin-resistance and associated anthropometric parameters in 
addition to ADPN levels.  
 
Hypothesis 2 
We hypothesize that ADPN levels in multi-year aerobic trained females will 
increase significantly in response to long-term, progressive aerobic training, but not in 
comparably trained males.  
 
Specific Aim 2 
To compare ADPN levels before and at the end of a long-term, progressive 
aerobic training protocol in middle-aged, multi-year aerobic trained males and females. 
We will analyze ADPN levels in both males (M) and females (F) from the trained 
marathoner group that has been training for and completing at least one full-distance 
(26.2 mile) marathon each year for five consecutive years. We will measure markers of 
insulin-resistance and associated anthropometric parameters in addition to ADPN levels. 
11 
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Abstract 
 
Adipose tissue secretes the adipokine, adiponectin (ADPN), which increases insulin 
sensitivity. Because some of the metabolic effects of exercise and ADPN are similar, 
exercise has been proposed to increase ADPN. However, most short-term (≤3 mos) and 
constant-effort exercise protocols have not produced increases in ADPN. Furthermore, no 
direct comparisons of male and female subjects on the effect of exercise on ADPN levels 
have been reported. We hypothesized that long-term (6 mos), progressive training would 
increase ADPN levels in both males and females. We recruited middle-aged, untrained 
males and females to participate in an interventional study employing a marathon training 
regimen progressing from 9.7 to 88.5 km (6 to 55 miles) per week over 6 mos. At 
baseline, we matched the mean ages of the male and female groups. We collected and 
stored fasting plasma samples and recorded body measurements at 0 (baseline) and 6 
mos. Stored samples were analysed for insulin, glucose, and ADPN. ADPN increased 
significantly among both males (from 5.89 ± 2.46 (mean ± SD) to 7.65 ± 3.18 μg/ml; p < 
0.05) and females (from 8.48 ± 3.22 to 10.56 ± 4.05 μg/ml; p < 0.05). The extent of the 
increase in ADPN was similar in the male (40.7 ± 50%; median, 12.1%) and female (27.0 
± 31.1%; median, 22.3%) groups. However, there was no significant reduction in insulin 
resistance as measured by the HOMA-IR scores in either group. We conclude that long-
term, progressive aerobic training increases circulating ADPN levels in middle-aged, 
untrained males and females.  
 
 
Key Words 
 
Exercise, intervention studies, human, adiponectin, sex differences 
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Introduction 
 
Adipose tissue, once thought to be exclusively a depot of fat, secretes several 
hormone-like proteins termed adipokines. Adipokines regulate satiety, lipid and 
carbohydrate metabolism, and insulin sensitivity. Decreased insulin sensitivity in the 
form of insulin resistance involves excessive insulin secretion in response to elevated 
blood glucose. Central obesity is on the rise in middle-aged men and women [1, 2] and 
increased adipose mass decreases the production of adiponectin (ADPN), an adipokine 
positively correlated with insulin sensitivity [3]. Mature adipocytes express and secrete 
ADPN (aka gbp28, Acrp30, and apM1), which occurs in human plasma at concentrations 
from 3 – 30 μg/ml. ADPN knockout mice on a high fat diet develop insulin resistance 
and coronary artery disease [4] while ADPN over-expression improves insulin sensitivity 
[5]. ADPN may preserve insulin sensitivity in middle-aged men and women [1, 2] since 
ADPN levels negatively correlate with obesity, hypertension, type II diabetes, 
hyperlipidemia, and metabolic syndrome [6].  
Aerobic exercise improves insulin sensitivity, blood pressure, lipoprotein profile, 
and metabolic and cardiovascular health [7]. Because some of these effects are similar to 
some of the effects of ADPN, exercise has been proposed to increase ADPN [7]. Several 
studies report that exercise increases [8 – 11] or does not increase [12 – 21] ADPN levels. 
In general, studies employing short-term (i.e. ≤ 3 mos) exercise protocols showed non-
significant changes in ADPN [12, 13, 17, 19 – 21]. Long-term (i.e.≤3 mos) exercise 
studies on overweight, obese, or insulin-resistant subjects increased ADPN [8 – 11], but 
not in normal-weight subjects [14,16]. In particular, long-term exercise studies 
employing progressive protocols showed significant increases in ADPN [10, 11]. 
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However, most long-term protocols used combined male/female cohorts [10, 11, 14, 15, 
18], but none have directly compared the effect of exercise in males and females using a 
long-term, progressive aerobic protocol. We hypothesized that untrained, overweight, 
middle-aged males and females would exhibit significant increases in ADPN in response 
to a long-term, progressive aerobic protocol. To test our hypothesis, we compared the 
effects of a progressive marathon-training program of 6 mos duration on ADPN levels in 
untrained, age-matched males and females. We found that ADPN levels increased 
significantly and to similar extents in both untrained males and females. This increase 
was accompanied by a significant reduction in waist circumference in the male group and 
by a significant reduction in body weight and hip circumference in the female group. 
 
 
Methods 
 
Subjects 
 
We recruited subjects from a large (n ≈ 600) local running club to participate in a 
6-mo, progressive, marathon running/walking program. The Institutional Review Board 
of Loma Linda University approved the research protocol. At the planning stage of our 
study, the local running club organizers informed us that in previous marathon training 
programs conducted by the club, the female attrition rate was about twice that of males. 
For this reason, we recruited more females than males. We presented the objectives and 
procedures of the study to the club members. We gave interested members an informed 
consent document explaining the procedures and risks and afforded opportunities to ask 
questions. Potential subjects signed the informed consent document before completing a 
screening questionnaire. Inclusion criteria were adult males and females who had never 
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participated in or trained for a marathon. Exclusion criteria were known cardiovascular, 
renal, hepatic, pulmonary, adrenal, pancreatic, thyroid, or pituitary disorder and smoking. 
 
Demographic Characteristics 
 
We separated the subjects into two groups: untrained males and untrained 
females. At baseline, we age-matched the male and female groups by excluding ten 
outlying female enrollees. The baseline cohort of males and females were numerically 
similar in mean ages and BMI values (Table 2.1.).  
During the 6 months of progressive training, our two groups exhibited different 
rates of attrition over which we had little control. Males with the highest BMI values (i.e. 
obese) dropped out to a greater extent than males of lower BMI categories, while females 
of the next two lower BMI categories dropped out to a greater extent than obese females. 
These opposing attrition trends caused the mean BMI values and ages of the two groups 
to diverge slightly (compare Tables 2.1. and 2.2.).  
The completing groups were not restricted to a particular ethnic group, but the 
proportion of Caucasians to non-Caucasians in the study was similar between the male 
and female groups with 36.4% and 22.2%, being Caucasians, respectively. We included 
postmenopausal females both on (n = 1) and not on (n = 2) hormone replacement therapy 
(HRT) because ADPN levels are reported to not differ between pre and postmenopausal 
women nor between postmenopausal women on HRT and those not on HRT [22]. We 
also included premenopausal females both on (n = 2) and not on (n = 6) oral 
contraceptive pills because ADPN levels in females are reported to be stable throughout 
the menstrual cycle [23], which we verified (data not showed). Female participants on 
oral contraceptives or HRT continued to use these throughout the study.
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Table 2.1. Physical characteristics in male and female groups at the 
baseline (0 mo). 
  
Untrained Male 
(n=14) 
Untrained Female 
(n=38)   
Variable Mean ± SD Mean ± SD p* 
age 47.0 ± 13.8 44.6 ± 11.0 NS 
HT 1.71 ± 0.03 1.63 ± 0.07 <0.0001 
WT 81.8 ± 13.8 77.9 ± 15.6 NS 
BMI 28.1 ± 4.7 29.4 ± 6.0 NS 
BF 26.5 ± 9.0 37.7 ± 6.9 <0.0005 
WST 98.4 ± 10.1 92.6 ± 13.1 NS 
HIP 103.5 ± 12.7 108.9 ± 12.6 NS 
WHR 0.96 ± 0.08 0.85 ± 0.07 <0.0005 
 
Abbreviation key: WT, total body weight (kg); HT, height (m); BMI, 
body mass index (kg/m2); WST, waist circumference (cm); HIP, hip 
circumference (cm); WHR, waist-to-hip ratio; BF, total body fat (%); 
NS, not significant; p*, significance between Untrained Male and 
Female groups by independent t-test. 
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Table 2.2. Physical characteristics and blood analytes in male and female groups at 
the baseline (0 mo) and end (6 mos). 
Abbreviation key: ADPN, plasma total adiponectin (μg/ml); FPI, fasting plasma insulin 
(μU/ml); FPG, fasting plasma glucose (mg/dl); HOMAIR, HOmeostasis Model 
Assessment of Insulin Resistance; WT, total body weight (kg); HT, height (m); BMI, 
body mass index (kg/m2); WST, waist circumference (cm); HIP, hip circumference (cm); 
WHR, waist-to-hip ratio; BF, total body fat (%); NS, not significant; LT, tests were 
conducted on log transformed variable; p, significance within Untrained Male and 
Female groups by paired t-test; †, effect of exercise training on ADPN levels between 
Untrained Male and Female groups by repeated-measures ANOVA after controlling for 
significant confounders; p*, significance between Untrained Male and Female groups by 
independent t-test. 
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Untrained Male 
(n=9) 
Untrained Female 
(n=11)   
Variable Time Mean ± SD Mean ± SD p* 
age 0 mo 47.1 ± 12.2 43.2 ± 12.1 NS 
HT 0 mo 1.72 ± 0.03 1.62 ± 0.07 <0.005 
WT 0 mo 79.5 ± 9.2 79.7 ± 17.0 NS 
 6 mo 78.2 ± 7.5 73.8 ± 13.4 NS 
  p NS <0.05   
BMI 0 mo 26.8 ± 2.5 30.5 ± 7.2 NS 
 6 mo 26.4 ± 2.1 28.3 ± 6.0 NS 
  p NS <0.05   
BF 0 mo 23.3 ± 4.8 38.1 ± 7.4 <0.001 
 6 mo 23.8 ± 5.7 36.5 ± 6.9 <0.001 
  p NS NS   
WST 0 mo 96.7 ± 7.6 93.1 ± 13.0 NS 
  6 mo 91.8 ± 7.4 88.0 ± 10.3 NS 
  p <0.05 NS   
HIP 0 mo 100.8 ± 6.6 110.3 ± 11.8 <0.05 
 6 mo 99.0 ± 4.2 103.7 ± 8.4 NS 
  p NS <0.05   
WHR 0 mo 0.96 ± 0.03 0.84 ± 0.08 <0.005 
 6 mo 0.93 ± 0.06 0.85 ± 0.06 <0.05 
  p NS NS   
ADPNLT 0 mo 5.89 ± 2.46 8.48 ± 3.22 NS 
 6 mo 7.65 ± 3.18 10.56 ± 4.05 NS 
  p <0.05† <0.05†   
FPI 0 mo 6.27 ± 3.48 8.97 ± 3.98 NS 
 6 mo 5.47 ± 1.66 8.46 ± 4.57 NS 
  p NS NS   
FPG 0 mo 93.6 ± 10.6 98.6 ± 5.4 NS 
 6 mo 97.4 ± 14.3 96.0 ± 9.1 NS 
  p NS NS   
HOMA-IR 0 mo 1.48 ± 0.88 2.21 ± 1.04 NS 
 6 mo 1.32 ± 0.44 2.03 ± 1.12 NS 
  p NS NS   
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Training Protocol 
 
All subjects followed the same progressive training protocol for 6 mos (Figure 
2.1.). The subjects met each Sunday at 7 a.m. with a pace group of their preferred speed 
to complete the assigned weekly long-distance run (Figure 2.1.). Subjects also completed 
additional progressive distances assigned for weekdays, but at times, days, and places of 
their choosing. The Sunday distance increased linearly at an average rate of 1.16 
km/week (km/week) from 3.2 to 32.2 km (2 to 20 miles). Weekday distance increased 
non-linearly during the first 8 weeks (from 6.4 to 32.2 km) and thereafter increased 
linearly at an average rate of 1.13 km/week (from 37 to 56.3 km) until the end of the 
study period of 24 weeks (i.e. 6 mos). Total weekly distance increased non-linearly 
during the first 8 weeks (from 9.7 to 45.1 km) and thereafter increased approximately 
linearly at an average rate of 2.08 km/week (from 53.1 to 88.5 km) until the end of the 
study (Figure 2.1.). We monitored adherence to the prescribed training protocol using 
self-reported daily running logs, which were collected each Sunday. Subjects remained in 
the same pace group throughout the study. We instructed subjects to maintain their pre-
intervention dietary habits during the course of the study, but dietary intakes were not 
monitored.  
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Figure 2.1.  Time course of long-term, progressive training protocol. Total weekly 
distance ( ) is the sum of weekday distance (○) and Sunday distance (∆). Anthropometric 
data and blood samples were collected at baseline (0 mo) and 6 mos as indicated by 
arrows. 
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Biochemical Measurements 
We collected fasting blood samples on Sundays, immediately before the start of 
the 3.2- and 32.2-km (2- and 20-mile), long-run distances corresponding to 0 and 6 mos, 
respectively. We asked the subjects to avoid strenuous exercise 2 days before the blood 
draws to avoid possible interfering pro-inflammatory cytokines [18]. We reminded the 
subjects of the 12-h fast requirement by telephone contact the evening before the morning 
blood draws. The 0-mo samples provided the baseline measurements, which also served 
as each subject’s control. We collected blood samples between 6 and 7 a.m. to minimize 
diurnal variation in ADPN levels [24]. A licensed phlebotomist drew venous blood from 
the median antecubital vein into a 10-ml glass vacuum tube (0268384; BD, Franklin 
Lakes, NJ) containing liquid K3 EDTA and protease inhibitor (250 KIU aprotinin /ml of 
blood; Calbiochem, San Diego, CA) and immediately placed on ice. We collected plasma 
within 1 h of blood collection by centrifuging at 1,900 x g in swinging buckets for 10 min 
at 4°C, aliquoted plasma samples, and immediately stored them in cryogenic vials at 
80°C until analysed. Before drawing the blood, we queried each subject about complying 
with the fast and omitted those not found to comply. Subjects subsequently found to have 
both fasting plasma insulin higher than 10 μU/ml and fasting plasma glucose higher than 
110 mg/ml would have been determined to have broken the fast and would have been 
excluded from the study. No subject exceeded the above-mentioned limits.  
We used sandwich ELISA-based assays to measure fasting total plasma ADPN 
(mg/ml; EZHADPN- 61K, LINCO Research, St. Charles, MO) and fasting plasma insulin 
(FPI; μU/ml; EZHI-14K, LINCO Research) according to kit instructions. We measured 
the absorbance in both assays at 450 nm on a plate reader (EL X 800, Universal 
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microplate reader, BIOTEK Instruments Inc., Winooski, VT). We measured fasting 
plasma glucose (FPG; mg/dl) using the glucose oxidase procedure (2810-1, Eagle 
Diagnostics, De Soto, TX) according to kit instructions. We measured the absorbance at 
500 nm. We measured the samples in duplicate, and re-assayed those with more than 
10% variation from fresh aliquots. The average coefficient of variation using ELISA kits 
for FPI assays was 3.9% (range: 3.2 – 4.4), for ADPN assays was 3.6% (range: 2.6 – 
4.25), and for glucose assays was 1.2% (range: 0.8 – 1.7). We calculated the Homeostasis 
Model Assessment of Insulin Resistance (HOMA-IR) scores using the following equation 
[25]:  
HOMA-IR = [FPI (μU/ml) X FPG (mg/dl)/18]/22.5 
 
 
 
Anthropometric Measurements 
 
Qualified personnel measured and recorded height (HT, m), body weight (WT, 
kg), total body fat (BF, %), and waist circumference (WST, cm) and hip circumference 
(HIP, cm) at 0 and 6 mos between 6 and 7 a.m. on the same day as the blood draw before 
the long run on Sundays. Anthropometrics were measured with the subjects wearing light 
running clothes without accessories and footwear. Waist circumference was recorded by 
placing a tape measure evenly and snugly at the natural waistline in a standing position 
where a waistline could be clearly identified. In the absence of such clearly identifiable 
waistline, the waist circumference was measured by placing a tape measure halfway 
between the top of the hip bone and the bottom of the rib cage. Hip circumference was 
measured by placing the tape measure evenly and snugly over the widest area of the hips. 
Waist-to-hip ratio (WHR) and body mass index (BMI) were calculated from the 
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measurements. Height (m) was measured at baseline (0 mo) using a stadiometer. The 
sliding part of the stadiometer was lowered so that the subject’s hair was pressed flat 
against the scalp. Total body fat was measured on non-athletic/normal setting using 
bioelectrical impedance (model: BF-679, TANITA Corporation, Arlington Heights, IL). 
All measurements were obtained in duplicate, recorded, and averaged.  
 
 
Statistical Analyses 
 
We used the Statistical Package for Social Sciences (version 17.0) for Windows 
(SPSS, Inc., Chicago, IL) to perform all statistical analyses. We considered the results 
statistically significant if a two-tailed p -value was less than or equal to 0.05. We used 
histograms and the Kolmogorov-Smirnov test for normality to determine whether the 
variables for the study groups were normally distributed. We log transformed and 
reassessed the variables that were not normally distributed. We used an independent t-test 
to assess each dependent variable between the study groups separately for each data 
collection point (i.e. 0-mo baseline and 6 mos). We also used an independent t-test to 
assess percent changes in the variables between the groups. We used a paired t-test to 
assess the difference in each dependent variable separately for each group when the 
outcome was not controlled for potential confounders. We included potential confounders 
as covariates in a multi-variable regression analysis using a repeated measure ANOVA to 
control for the influence of changes in confounders on the outcome variable ADPN only. 
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Results 
 
Subject Compliance 
 
We enrolled subjects meeting the inclusion and exclusion criteria. Cohort sizes at 
each stage of the study are shown in Figure 2.2. Of the original 62 enrolled subjects, 
retention among male subjects was almost three times as high (64%) as females (23%). 
We carried out data analyses on a total of 20 subjects (i.e. males = 9; females = 11) who 
completed the 6-mo training and provided complete data sets at baseline (0 mo) and 6 
mos. 
30 
 
 
 
 
 
Figure 2.2.  Sample size and gender composition at each stage of the study. 
 
 
 
127 assessed for eligibility 
n = 48 
Completed 6-mo training protocol 
and End (6 mo) measurements 
n = 14 Enrollment 
Baseline (0 mo) measurements 
Beginner Male Beginner Female 
n = 14 n = 38 
n = 9 n = 11 
65 did not meet inclusion 
criteria 
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Adiponectin Levels 
 
ADPN levels increased significantly at the end of 6 mos in both the male and 
female groups. At baseline and at the end of 6 mos of training, the ADPN levels in the 
female group were higher than those in the male group, but not significantly (Table 2.2.). 
The percent change in ADPN (Δ ADPN %) was not significantly different between males 
(40.7 ± 50.0%; median, 12.1%) and females (27.0 ± 31.1%; median, 22.3%). After 
controlling for percent changes in WST and BMI using a repeated-measure ANOVA, the 
effect of 6-mo exercise on ADPN levels of males and females was significant (p < 0.05, 
Table 2.2., Figure 2.3.).  
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Figure 2.3.  Plasma adiponectin levels at baseline and end of 6 mos aerobic training in 
groups identified by gender. Adiponectin levels (mean ± SEM) at the baseline (0 mo, 
open bars) and end (6 mos, filled bars) were significant in males and females, as 
determined by a repeated-measures ANOVA after controlling for percent change in 
BMI and percent change in WST. Asterisk (*) indicates p < 0.05. Sample sizes of 
each group are indicated in parentheses. 
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Insulin, Glucose, and HOMA-IR Score 
 
Male and female groups exhibited similar baseline and 6-mo FPI, FPG and 
HOMA-IR score (Table 2.2.). Furthermore, FPI, FPG, and HOMA-IR score did not 
change at the end of the 6 mos of training within either group. 
 
 
Anthropometric Measurements 
 
The male and female groups exhibited similar WT, BMI, and WST measurements 
at the beginning and at the end of the study, however, the females had significantly 
higher baseline HIP (Table 2.2.). BF among females was significantly higher than among 
males at the beginning and at the end of the study. Males exhibited a significant 5% 
reduction in WST (95% CI, -9.4 to -0.4), while WT, BMI, HIP, WHR decreased non-
significantly and BF remained unchanged (Table 2.2.). Females exhibited a significant 
7% reduction in WT and BMI (95% CI, -11.8 to -1.4), and a significant 6% reduction in 
HIP (95% CI, -9.4 to -1.9). In females, the WST decreased by 5% (95% CI, -10.9 to 1.2) 
and the BF by 3% (95% CI, -11.9 to 5.4), but not significantly, and the WHR remained 
almost constant. 
 
 
Discussion 
 
In the present study, we compared the effects of long-term, progressive aerobic 
exercise training on adiponectin (ADPN) levels between untrained, middle-aged men and 
women. Previous studies have been mostly conducted on mixed male/female or single-
gender cohorts. The influence of gender, if any, on changes in ADPN due to exercise has 
not been studied. Our results show that long-term, progressive aerobic training 
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significantly increases circulating levels of ADPN in untrained, middle-aged males and 
females. These increases were accompanied by significant reductions in some body 
measurements, but without changes in insulin resistance. The increase in ADPN levels 
was similar in males and females. 
 
 
Effects of Reductions in Anthropometrics 
 
In the female group, we observed a 7% decrease in WT and BMI, a 6% decrease 
in HIP, and a 5% decrease in WST. In the male group, we also observed only a 2% 
decrease in WT, BMI, and HIP and a 5% decrease in WST. Because there were more 
obese females than obese males, the decrease in WT in the female group was more than 
in the male group. Compared to long-term studies [8 – 11] that employed obese, insulin-
resistant, or diabetic subjects, the anthropometric changes observed in our middle-aged, 
untrained subjects were modest. The percent BF decreased non-significantly in both male 
and female groups. The lack of correlation between changes in ADPN and changes in 
body fat has been reported [10, 13]. The effect of exercise on ADPN levels cannot be 
properly assessed unless controlled for concomitant anthropometric changes [26]. The 
observed increases in ADPN in our male and female groups were significant after 
adjusting for the percent changes in BMI and WST. Significant increases in ADPN levels 
have been reported regardless of the extent of body weight loss [8 – 11, 27]. These and 
our findings suggest that weight loss may not be necessarily associated with exercise-
induced increases in ADPN, although weight loss may be obligatorily associated with 
increases in ADPN in dietary restriction studies [27]. In animal studies, ADPN levels are 
regulated differently by diet restriction versus exercise [28].  
35 
Effects of Gender 
 
Females, in general, exhibit higher ADPN levels than males [29]. As stated 
previously, most long-term (>3 mos) protocols studying the effects of exercise on ADPN 
have been conducted on mixed male/female or single-gender cohorts [10, 11, 14, 15, 18, 
30]. Long-term exercise interventions have shown increases in ADPN in females [8, 9], 
but not in males [16]. Progressive exercise studies have shown increases in ADPN in a 
mixed male/female cohort [11] and a male only cohort [10]. In our long-term, progressive 
exercise study of untrained, middle-aged males and females, both gender groups 
exhibited significant percent increases in ADPN. The present study was conducted on 
subjects with no previous long-term, endurance training experience. The extent to which 
different exercise training backgrounds play a role in gender-specific exercise-induced 
changes in ADPN levels remains to be explored. Due to different rates of attrition in the 
male and female groups, the difference in mean ages diverged from 2.4 years for baseline 
groups (Table 2.1.) to 3.9 years for the completing groups (Table 2.2.). Differences in age 
do not affect ADPN levels in females [31 – 33], but aging may increase ADPN levels in 
normal-weight males over the age of 65 [34 – 35]. However, all of the males in our 
cohort were under the age of 65. Hence, the mean age difference of 3.9 years between the 
completing male and female groups is unlikely to significantly affect the comparability of 
our study groups either in terms of ADPN levels or changes in ADPN levels. The issue of 
whether the two groups are comparable is complicated by the fact that they are different 
sexes. For example, the concept of BMI is not directly transportable between the two 
sexes because of well known gender-based differences in bone mass and fat distribution. 
In addition, it is well known that ADPN levels in females on average are higher than in 
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males [24]. However, in terms of mean age, BMI, exercise history, and ethnicity, these 
two groups are comparable for the main purpose of our study, which is to compare the 
effects of 6 months aerobic training on changes in ADPN levels between untrained, 
middle-aged males and females. 
 
 
Effects of Insulin Resistance 
 
Reported correlations between changes in insulin resistance and changes in 
ADPN have been inconsistent. Some have shown that ADPN increases with improved 
insulin sensitivity [36, 37]; others have shown that ADPN increases without improvement 
in insulin sensitivity [15, 38]; and still others have shown no change in ADPN despite 
improved insulin sensitivity [12, 13, 39]. In our 6-mo study, significant increases in 
ADPN levels occurred in both the male and female groups without corresponding 
reductions in HOMA-IR score, a surrogate measure of insulin resistance. Because insulin 
sensitivity gradually decreases to control levels within 2 – 4 days after exercise [40, 41], 
our subjects were asked to refrain from exercise 2 days prior to giving a blood sample. 
Our findings suggest that exercise-induced increases in ADPN in untrained, middle-aged, 
overweight males or females occur without changes in insulin sensitivity. Several factors 
contributed to the relatively small sample size of our study. These were (i) the inclusion 
of only untrained running club members, (ii) the exclusion of potential subjects on 
prescription medicines influencing ADPN levels, and (iii) the contribution of long-term, 
strenuous exercise intervention to injury-related dropouts, especially among the untrained 
females. 
 
37 
Conclusions 
 
We conclude that long-term progressive aerobic training significantly increases 
plasma ADPN levels in untrained, middle-aged, overweight males and females to similar 
extents, but without significantly affecting insulin resistance. The significant reductions 
in some anthropometric measurements, such as WT and WST, do not appear to influence 
changes in ADPN. Thus, gender does not seem to significantly affect exercise-induced 
increases in ADPN due to long-term progressive training in untrained, middle-aged, 
overweight subjects. 
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Abstract 
 
 Aerobic training and the adipokine, adiponectin (ADPN), both increase insulin 
sensitivity. Because the metabolic effects of ADPN and aerobic training are similar, 
aerobic training has been proposed to increase ADPN. Physically active adolescent 
females show higher ADPN levels compared to sedentary controls. Long-term aerobic 
training studies show greater increases in ADPN levels in untrained females than in 
untrained males, and previously trained young males show no increase in ADPN levels. 
Consequently, we hypothesized that long-term (6 months), progressive aerobic training 
would increase ADPN levels in trained, middle-aged females, but not in comparably 
trained males. We recruited aerobically trained, normal-weight, middle-aged males and 
females to participate in a marathon training protocol progressing from 9.7 to 88.5 km (6 
to 55 miles) per week over 6 months. We collected and stored fasting plasma samples and 
recorded body measurements at 0 (baseline) and 6 months. Stored samples were analyzed 
for insulin, glucose, and ADPN. ADPN increased significantly among females [from 
18.37 ± 10.39 (mean ± SD) to 22.50 ± 9.87 µg/ml; P<0.05], but non-significantly among 
males (from 6.69 ± 4.47 to 8.10 ± 5.57 µg/ml; P=0.2). No significant reduction in insulin 
resistance or anthropometric measurements occurred in either group. We conclude that 
long-term, progressive aerobic training increases circulating ADPN levels in trained, 
middle-aged, normal-weight females, but not in comparable males.  
 
 
Key Words 
adiponectin, exercise, human, intervention studies, sex differences 
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Introduction 
 
Central obesity is on the rise in middle-aged men and women [1, 2] and increased 
adipose mass decreases the production of adiponectin (ADPN), an adipokine positively 
correlated with insulin sensitivity [3]. Mature adipocytes express and secrete ADPN (aka 
gbp28, Acrp30, and apM1). ADPN knockout mice on a high fat diet develop insulin 
resistance and coronary artery disease [4], while ADPN over-expression improves insulin 
sensitivity [5]. Higher levels of ADPN may preserve insulin sensitivity in middle-aged 
men and women [1, 2] since ADPN levels negatively correlate with obesity, high blood 
pressure, type II diabetes, hyperlipidemia, and metabolic syndrome [6].  
Aerobic exercise improves insulin sensitivity, blood pressure, lipoprotein profile, 
and metabolic and cardiovascular health [7]. Because some of the effects of aerobic 
exercise training and ADPN are similar, aerobic training has been proposed to increase 
ADPN levels [7]. Cross-sectional studies reported significantly higher ADPN levels in 
physically active versus sedentary adolescent females [8, 9].  
At the end of a long-term [24 months (mos)] aerobic intervention involving 
untrained, middle-aged, obese subjects, ADPN levels increased two-fold more in females 
than in males [10]. Long-term (6 mos), progressive aerobic training also increased ADPN 
levels almost twice as much (22.3%) in untrained, middle-aged, overweight females as in 
untrained males (12.1%) [11], while long-term studies on young, elite male rowers 
showed no changes in ADPN levels [12, 13]. Thus various studies indirectly suggest that 
ADPN levels may increase more in physically active females than in males, but no study 
has yet directly compared the effect of long-term aerobic training on ADPN levels in 
trained males and females.  
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We hypothesized that trained, normal-weight, middle-aged females would exhibit 
significantly greater increases in ADPN in response to long-term, progressive aerobic 
training than in similarly trained males. To test our hypothesis, we compared the effects 
of a 6-mo, progressive, marathon-training program on ADPN levels in trained male and 
female groups that were similar in baseline BMI and age. Consistent with our hypothesis, 
we found that ADPN levels increased significantly in trained females by the end of 6-mo 
training, but non-significantly in males. 
 
 
Methods 
 
Subjects 
We recruited subjects from a large (n ≈ 600) local running club to participate in a 
6-mo, progressive, marathon training program. The Institutional Review Board of Loma 
Linda University approved the research protocol. We presented the objectives and 
procedures of the study to the club members and gave interested members an informed 
consent document explaining the procedures and risks and afforded opportunities to ask 
questions. Potential subjects signed the informed consent document before completing a 
screening questionnaire. Inclusion criteria were adult males and females that have been 
training for and completing a minimum of one full-distance marathon per year for each of 
the past five years. Exclusion criteria were known cardiovascular, renal, hepatic, 
pulmonary, adrenal, pancreatic, thyroid, or pituitary disorder and smoking.  
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Demographic Characteristics 
We separated the subjects into two groups by gender: trained males and trained 
females. As shown in Table 3.1., the male and female cohorts were similar in mean age 
and mean BMI.  
During the 6 mos of progressive training, the two groups exhibited similar rates of 
attrition. However, because younger females dropped out to a greater extent than younger 
males, the mean ages of the male and female groups diverged slightly, but not 
significantly (compare Tables 3.1. and 3.2.). Several factors contributed to the relatively 
small sample size of our study. These were (i) the inclusion of only middle-aged, multi-
year trained running club members and (ii) the exclusion of potential subjects on 
prescription medicines known to influence ADPN levels.  
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Table 3.1. Physical characteristics in male and female 
groups at the baseline (0 mo). 
  
Trained Male 
(n=14) 
Trained Female 
(n=10)  
Variable Mean ± SD Mean ± SD p* 
age 51.5 ± 11.1 54.9 ± 10.6 NS 
HT 1.77 ± 0.05 1.63 ± 0.09 <0.001 
WT 81.1 ± 12.8 63.3 ± 11.7 <0.005 
BMI 25.8 ± 3.7 23.9 ± 3.5 NS 
BF 22.5 ± 6.4 28.2 ± 8.1 NS 
WST 93.1 ± 11.6 80.0 ± 13.1 <0.05 
HIP 99.4 ± 7.7 98.9 ± 8.9 NS 
WHR 0.94 ± 0.07 0.81 ± 0.09 <0.005 
 
Abbreviation key: age (yr); HT, height (m); WT, total body 
weight (kg); BMI, body mass index (kg/m2); BF, total body 
fat (%); WST, waist circumference (cm); HIP, hip 
circumference (cm); WHR, waist-to-hip ratio; NS, not 
significant; p*, significance between Trained Male and 
Trained Female groups by independent t-test. 
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Table 3.2. Physical characteristics and blood analytes in trained male and female groups 
at the baseline (0 mo) and end (6 mos). 
Abbreviation key: age (yr); HT, height (m); WT, total body weight (kg); BMI, body mass 
index (kg/m2); BF, total body fat (%); WST, waist circumference (cm); HIP, hip 
circumference (cm); WHR, waist-to-hip ratio; ADPN, plasma total adiponectin (µg/ml); 
FPI, fasting plasma insulin (µU/ml); FPG, fasting plasma glucose (mg/dl); HOMA-IR, 
HOmeostasis Model Assessment of Insulin Resistance; NS, not significant; LT, tests were 
conducted on log transformed variable; p, significance within Trained Male and Trained 
Female groups by a paired t-test; p*, significance between Trained Male and Trained 
Female groups by independent t-test. 
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Trained Male 
(n=10) 
Trained Female 
(n=8)   
Variable Time Mean ± SD Mean ± SD p* 
age 0 mo 50.9 ± 11.5 58.8 ± 6.3 NS 
HT 0 mo 1.75 ± 0.03 1.61 ± 0.08 <0.005 
WT 0 mo 75.8 ± 9.6 63.4 ± 11.8 <0.05 
 6 mo 75.4 ± 9.9 64.4 ± 12.6 0.06 
 p NS NS  
BMI 0 mo 24.9 ± 3.0 24.4 ± 3.5 NS 
 6 mo 24.7 ± 3.1 24.8 ± 3.8 NS 
 p NS NS  
BF 0 mo 19.3 ± 7.7 30.9 ± 11.2 <0.05 
 6 mo 19.2 ± 7.7 30.1 ± 8.1 <0.05 
 p NS NS  
WST 0 mo 86.7 ± 11.4 80.4 ± 14.1 NS 
 6 mo 86.4 ± 11.2 79.5 ± 10.7 NS 
 p NS NS  
HIP 0 mo 93.5 ± 11.3 99.1 ± 8.7 NS 
 6 mo 93.0 ± 12.4 98.5 ± 9.3 NS 
 p NS NS  
WHR 0 mo 0.93 ± 0.10 0.81 ± 0.10 <0.05 
 6 mo 0.93 ± 0.09 0.81 ± 0.07 <0.005 
 p NS NS  
ADPNLT 0 mo 6.69 ± 4.47 18.37 ± 10.39 <0.005 
 6 mo 8.10 ± 5.57 22.50 ± 9.87 <0.005 
 p NS <0.05  
FPI 0 mo 5.69 ± 2.62 4.99 ± 3.63 NS 
 6 mo 4.97 ± 2.94 5.11 ± 3.22 NS 
 p NS NS  
FPG 0 mo 101.4 ± 30.2 101.7 ± 12.1 NS 
 6 mo 97.9 ± 15.2 95.6 ± 17.4 NS 
 p NS NS  
HOMA-IR 0 mo 1.43 ± 0.73 1.28 ± 1.00 NS 
 6 mo 1.23 ± 0.79 1.25 ± 0.90 NS 
  p NS NS   
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Subjects were not restricted to a particular ethnic group, but the proportion of 
Caucasians to non-Caucasians in the completing cohorts of the study were similar with 
80.0% and 87.5%, being Caucasians in the male and female groups, respectively. We 
included postmenopausal females both on (n=3) and not on (n=4) hormone replacement 
therapy (HRT) because ADPN levels have been reported to not differ between 
postmenopausal women on HRT and those not on HRT [14]. We also included two 
premenopausal women, who did not complete the study, and a perimenopausal female 
(age 53 yrs) on oral contraceptive (OC) because ADPN levels in females are reported to 
be stable throughout the menstrual cycle [15, 16] and unaffected by the use of OCs [16]. 
The ADPN levels have also been reported to not differ between premenopausal women 
not on OC and postmenopausal women not on HRT [14]. Female participants on oral 
contraceptives or HRT continued to use these throughout the study.  
 
 
Training Protocol 
All subjects followed the same progressive training protocol for 6 mos, which is 
described in detail elsewhere [11]. The Sunday distance increased linearly at an average 
rate of 1.16 km/week (km/week) from 3.2 to 32.2 km (2 to 20 miles) over a period of 6 
mos. Weekday and total weekly distances increased non-linearly during the first 8 weeks 
and thereafter increased linearly until the end of 6 mos (Figure 3.1.). We monitored 
adherence to the prescribed training protocol using self-reported daily running logs, 
which were collected each Sunday. Subjects remained in the same pace group throughout 
the study. We instructed subjects to maintain their pre-intervention dietary habits during 
the course of the study, but dietary intakes were not monitored.  
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Figure 3.1.  Time course of long-term, progressive training protocol. Total weekly 
distance () is the sum of weekday distance () and Sunday distance (). 
Anthropometric data and blood samples were collected at baseline (0 mo) and 6 mos as 
indicated by arrows.  
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Biochemical Measurements 
Biochemical measurements are described in detail elsewhere [11]. Briefly, we 
collected fasting blood samples from the median cubital vein on Sundays, immediately 
before the start of the 3.2- and 32.2-km (2- and 20-mile), long-run distances 
corresponding to 0 and 6 mos, respectively. We collected plasma by centrifugation, 
separated plasma samples into 0.5 ml aliquots, and immediately stored them at -80oC 
until analyzed. We used spectrophotometric, sandwich ELISA-based assays for fasting 
total plasma ADPN (mg/ml; EZHADPN-61K, LINCO Research, St. Charles, MO) and 
fasting plasma insulin (FPI; µU/ml; EZHI-14K, LINCO Research) and the liquid oxidase 
procedure (2810-1, Eagle Diagnostics, De Soto, TX) for fasting plasma glucose (FPG; 
mg/dl). We calculated the HOmeostasis Model Assessment of Insulin Resistance 
(HOMA-IR) scores using the following equation [17]: HOMA-IR = [FPI (µU/ml) x FPG 
(mg/dl)/18]/22.5  
 
 
Anthropometric Measurements 
Qualified personnel measured and recorded height (HT, m), body weight (WT, 
kg), total body fat (BF, %), waist circumference (WST, cm) and hip circumference (HIP, 
cm) as previously described [11]. These measurements were taken at 0 and 6 mos 
between 6-7 AM on the same day as the blood draw immediately before the long run on 
Sunday. Waist-to-hip ratio (WHR) and body mass index (BMI) were calculated from the 
measurements. Height (m) was measured at baseline (0 mo) using a stadiometer. Total 
body fat was measured on standard adult mode (non-athlete mode) setting using 
53 
bioelectrical impedance (model BF-679, TANITA Corporation, Arlington Heights, IL). 
All measurements were obtained in duplicate, recorded, and averaged.  
 
 
Statistical Analyses 
We used the Statistical Package for Social Sciences (version 17.0) for Windows 
(SPSS, Inc., Chicago, IL) to perform all statistical analyses. We considered the results 
statistically significant if a two-tailed P-value was less than or equal to 0.05. We used 
histograms and the Kolmogorov-Smirnov test for normality to determine whether the 
variables for the study groups were normally distributed. We log transformed and 
reassessed the variables that were not normally distributed. We used an independent t-test 
to assess each dependent variable between the study groups separately for each data 
collection point (i.e. 0-mo baseline and 6 mos). We also used an independent t-test to 
assess percent changes in the variables between the groups. We used a paired t-test to 
assess the difference in each dependent variable separately for each group.  
 
Results 
Subject Compliance 
We enrolled subjects meeting the inclusion and exclusion criteria. Cohort sizes at 
each stage of the study are diagramed in Figure 3.2. Of the original 27 enrolled subjects, 
retention among trained male and trained female subjects was the same (66.7%). We 
carried out data analyses on a total of 18 subjects (i.e. males = 10; females = 8) who 
completed the 6-mo training and provided complete data sets at baseline (0 mo) and 6 
mos.  
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Adiponectin Levels 
The levels of ADPN increased at the end of 6 mos of training in both male and 
female groups, but significantly only among the trained females (Fig. 3.3.). In the female 
group ADPN levels at the baseline and at the end of 6 mos of training were significantly 
higher by three-fold than in the male group (Table 3.2.). The percent increases in ADPN 
were not significantly different between males (22.0 ± 43.4%; median, 11.4%) and 
females (38.7 ± 53.2%; median, 18.8%).  
 
 
Insulin, Glucose, and HOMA-IR score 
Trained male and female groups exhibited similar FPI and FPG levels and 
HOMA-IR scores at baseline and at the end of the study (Table 3.2.). Furthermore, FPI 
and FPG levels and HOMA-IR scores did not change by the end of the 6 mos of training 
within either group.  
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Figure 3.2.  Sample size and gender composition at each stage of the study.  
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Figure 3.3.  Plasma adiponectin levels at baseline and at end of 6 mos aerobic training 
in groups identified by gender. Increase in adiponectin levels (mean ± SEM) between 
baseline (0 mo, open bars) and end (6 mos, filled bars) was significant in trained 
females, but not trained males, as determined by a paired t-test. Asterisk (*) indicates 
P<0.05. Sample sizes of each group are indicated in parentheses. 
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Anthropometric Measurements 
The trained males had higher WT than females. The difference was significant at 
the baseline, but non-significant at the end of the 6-mo training. The male and female 
groups exhibited similar BMI, WST, and HIP measurements at the baseline and at the 
end of 6 mos training. The females had significantly higher BF and lower WHR 
compared to males at the baseline and at the end of 6 mos training. (Table 3.2.).  
Both males and females exhibited negligible and non-significant reductions in 
mean WST and HIP, and negligible and non-significant increases in mean WHR and BF. 
Additionally, males exhibited negligible reductions in WT and BMI, whereas females 
exhibited negligible increases in WT and BMI (Table 3.2.).  
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Discussion 
In the present study, we compared the effects of long-term, progressive aerobic 
training on adiponectin (ADPN) levels in trained male and female marathoners who were 
middle-aged and normal-weight. Few exercise interventions measuring changes in ADPN 
levels have been conducted on middle-aged athletes. Because previous studies have 
mostly focused on trained, single-gender cohorts, the influence of gender on exercise-
induced changes in ADPN has not been adequately addressed. Our results show that 
long-term, progressive aerobic training of 6 mos duration increases circulating levels of 
ADPN to a significantly greater extent in trained, middle-aged females than in similarly 
trained males.  
 
 
Effects of Gender 
Females, in general, exhibit higher ADPN levels than males [18]. In our previous 
study on untrained, middle-aged subjects undergoing 6-mo, progressive aerobic training, 
ADPN levels in females were slightly higher both at baseline and at 6 mos compared to 
males, and both males and females showed significant and similar increases in ADPN 
levels [11]. However, in the present study on trained, middle-aged marathoners, the male-
female differences in ADPN levels at baseline and at 6 mos were significantly larger with 
the trained females exhibiting ADPN levels three times higher than the comparably 
trained males. In addition, our 6-mo, aerobic protocol increased ADPN significantly in 
trained females (P<0.05), but non-significantly (P=0.19) in trained males, which is 
similar to a 6-mo study showing no significant increases in ADPN levels among young, 
trained male rowers [13].  
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Aerobically exercising females derive proportionately more of their expended 
energy from free fatty acid oxidation than do males [19, 20]. ADPN expression positively 
correlates with hormone-sensitive lipase activity in females [21], which regulates 
lipolysis in adipose tissue. Thus, our observation that trained exercising females exhibit 
higher levels and greater increases in ADPN than comparably trained males may be 
metabolically linked to trained females’ greater capacity to mobilize and use mobilized 
free fatty acids to fuel their aerobic exercise.  
 
 
Effects of Training History 
When comparing ADPN levels between untrained subjects from our previous 
study [11] and trained subjects from our current study, the baseline ADPN levels in the 
trained males were not higher than those in the untrained males [11]. However, the 
baseline ADPN levels in the trained females were twice those in the untrained females 
[11]. Because of differences in mean age, BMI, and ethnicity between the cohorts of 
these two studies, we cannot readily compare untrained and trained subjects from the 
same gender. However, it appears that several years of prior aerobic training may 
increase ADPN levels much more in females than in males.  
 
 
Effects of Insulin Resistance 
Aerobic training lowers resting levels of insulin [12]. However, we did not expect 
the 6-mo training protocol to produce significant increases in insulin sensitivity because 
our subjects already were trained and exhibited HOMA-IR scores indicative of healthy 
insulin sensitivity at baseline. In fact, we did not observe any changes in insulin 
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sensitivity following 6 mos of training. Our findings suggest that exercise-induced 
increases in ADPN can occur without measurable reduction in HOMA-IR scores in 
trained males and females.  
 
Effects of Body Measurement Changes 
Because all of our subjects were previously trained, we did not expect the 6-mo 
aerobic training to produce significant changes in body measurements, nor did we 
observe any. Elite male rowers also showed no changes in body weight in response to 6-
mo training [13]. Weight loss has been considered by some to be a necessary correlate to 
increased ADPN levels [22-25]. However, studies using long-term aerobic training have 
reported increases in ADPN levels without weight loss in untrained [10, 11, 26] and 
trained subjects [12, 13]. These and our current findings with trained subjects suggest that 
weight loss is not necessary for exercise-induced increases in ADPN.  
 
Conclusions 
We conclude that 6-mo, progressive, aerobic training increases circulating ADPN 
levels in multi-year trained females to a larger extent than in similarly trained males. To 
our knowledge, our findings are the first to show that only trained females benefit in 
terms of increased ADPN levels by the additional training. In addition, our findings show 
that exercise-induced increases in ADPN levels can occur in the absence of changes in 
insulin-sensitivity or weight loss in previously trained individuals. Comparing the current 
findings with those from our previous study on untrained subjects, it appears that males 
on the one hand show little to no increase in ADPN levels beyond what occurs during 6 
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mos of progressive training. On the other hand, ADPN levels in females increase beyond 
6 mos of marathon training if aerobic training continues. Thus, the extent of exercise-
induced increase in ADPN levels appears to be gender-specific; limited in males, but 
extended in females.  
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CHAPTER FOUR 
DISCUSSION/CONCLUSION 
 
 
Goal of Dissertation 
 
The overall goal of the dissertation was to elucidate the influence of gender and 
aerobic training background on exercise-induced increase in adiponectin. 
Our general hypothesis was that long-term aerobic training increases total 
circulating adiponectin and that gender and exercise training background strongly 
influence the extent of the exercise-induced increase in adiponectin.  
The general hypothesis included two specific hypotheses –  
In Hypothesis 1, we hypothesized that ADPN levels increase significantly in 
previously untrained males and females in response to long-term, progressive aerobic 
training. To test this hypothesis, our specific aim was To compare ADPN levels before 
and at the end of a long-term, progressive aerobic training regimen in middle-aged, 
untrained males and females. We measured ADPN levels in untrained male and female 
subjects that had never trained for or participated in a full-distance (26.2 mile) marathon. 
In addition to ADPN levels we measured markers of insulin-resistance and 
anthropometric parameters.  
In Hypothesis 2, we hypothesized that ADPN levels in multi-year aerobic trained 
females increase significantly in response to long-term, progressive aerobic training, but 
not in comparably trained males. To test this hypothesis, our specific aim was To 
compare ADPN levels before and at the end of a long-term, progressive aerobic training 
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regimen in middle-aged, multi-year aerobic trained males and females. We measured 
ADPN levels in trained male and female subjects that have been training for and 
completing at least one full-distance (26.2 mile) marathon each year for the five previous 
consecutive years. We measured markers of insulin-resistance and anthropometric 
parameters in addition to ADPN levels. 
 
Major Findings of The Dissertation 
Our study design and methodology achieved the goal of the project and we 
conclude that gender and aerobic training background strongly influence exercise-
induced increases in ADPN. Our findings also show that exercise-induced increases in 
ADPN levels can occur independently of insulin-sensitivity changes in both untrained 
and trained subjects. In addition, we have shown that exercise-induced increases in 
ADPN can occur independently of weight loss in both untrained and previously aerobic-
trained individuals. On the one hand, it appears that males, show little to no increase in 
ADPN levels beyond that which occurs during 6 mos of progressive marathon training. 
On the other hand, females show increased ADPN levels beyond 6 mos of marathon 
training program if aerobic training continues. Thus, the extent of exercise-induced 
increase in ADPN levels appears to be gender- and training background-specific with 
ADPN levels increasing in males and reaching a plateau at relatively moderate levels of 
training, while in females ADPN levels increase with increasing durations of training.  
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Contributions to The Field 
Our comprehensive study fills in the gaps in the literature by answering the 
following questions: 
1. Does long-term aerobic training increase ADPN in healthy subjects? 
Most of the studies in the literature have been conducted on overweight [1, 2], 
obese [3-7], or insulin-resistant or DM2 subjects [3, 8-11]. Although these studies 
showed an increase in ADPN, studies conducted on untrained and trained healthy 
subjects showed no changes in ADPN [12, 13]. Our study showed a significant increase 
in healthy untrained male and female subjects and healthy trained female subjects and a 
weaker trend of increase P=0.19 in ADPN in healthy trained males. Therefore, we 
conclude that long-term aerobic training does increase ADPN in healthy subjects.  
2. Is weight loss necessary for an increase in ADPN? 
The general opinion in the field is that greater than 10% weight loss brought about 
by caloric restriction, aerobic exercise intervention, and/or liposuction is needed to 
increase ADPN levels [3, 7]. However, some studies employing progressive training 
protocols showed increased ADPN levels without significant weight loss [9]. Many 
studies that observed increased ADPN levels due to exercise training intervention did not 
control for reductions in weight, body fat, waist circumference [3, 8, 9, 14, 15] to 
correctly interpret if intervention-induced, specifically exercise intervention-induced, 
increases in ADPN levels were due to intervention alone or due to reductions in 
anthropometric measurements.  
Our untrained male and female subjects showed a reduction in body weight and 
waist circumference [16]. After statistically controlling for these changes in a repeated 
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measure ANOVA, the increase in ADPN was still significant. The trained subjects in our 
study showed no decrease in anthropometric measures, but the trained females showed a 
significant increase in ADPN and the trained males showed a trend of increased (P=0.19) 
ADPN levels at the end of 6-mo progressive aerobic training (submitted). Therefore, we 
conclude that weight-loss is not a prerequisite for exercise-induced increases in ADPN.  
3. Does gender influence aerobic exercise-induced increase in ADPN? 
Most studies were conducted on cohorts with male-female subjects together [1, 6, 
7, 9, 10, 12, 14, 17] or male [4, 13, 15, 18] or female [2, 8] subjects. Studies employing 
female-only cohorts reported increases in ADPN while most studies employing male-
only cohorts reported no changes. Ring-Dimitriou et al. reported two-times higher 
increases in ADPN in females compared to males [9]. Until our two studies, no study had 
compared males and females during same exercise intervention. Our untrained and 
trained females showed a significant and two times greater increase in ADPN levels 
compared to our untrained and trained males. Our untrained males showed a significant 
increase in ADPN, but not the trained males. Therefore, we conclude that exercise-
induced increase in ADPN is gender specific.  
4. Is aerobic exercise-induced increase in ADPN affected by different 
training backgrounds? Are there differences in aerobic exercise-induced increases 
in ADPN in people with and without aerobic training background? 
Most long-term exercise intervention studies have been conducted on untrained 
subjects [1-11, 14, 15, 17-20] with only a few on trained subjects [13, 21]. No previous 
study, however, compared changes in ADPN levels in trained and untrained subjects 
undergoing the same exercise training protocol. Our comprehensive study sought to 
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answer the question: Do untrained subjects show higher increases in ADPN levels, as 
they have not been conditioned to exercise training? Our trained and untrained females 
both showed similar (median, ~20%) increases in ADPN. Our trained and untrained 
males also showed similar (median, ~10%) increases in ADPN. Therefore we conclude 
that aerobic exercise-induced increase in ADPN does not differ according to training 
background.  
 
Assumptions and Limitations of The Study 
Our study groups were based on self-reported information concerning the 
subjects’ exercise training and medical history. The results of our studies should be 
interpreted with attention to the following limitations –  
1. Body composition –  
We used the bioelectric impedance method (model: BF-679, TANITA 
Corporation, Arlington Heights, IL) for measuring total body fat as a percent of total 
body weight. This method does not give differential body fat measurement data 
associated with different compartments of body fat, subcutaneous and visceral. Hence, 
we could not associate the increase in ADPN levels with loss of a specific compartment 
of fat, particularly visceral fat.  
We measured body fat of both trained and untrained subjects using the standard 
mode of the TANITA® model. According to our trial runs with the TANITA® model, 
athlete mode understates the total body fat measurements whereas standard mode 
overstates the total body fat measurements of a trained subject. To compare body fat 
composition of the untrained group to that of the trained group, it was not advisable to 
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measure the untrained subjects on the standard mode and the trained subjects on athlete 
mode, as it would yield a much larger difference in the mean percent body fat of two 
groups and introduce error.  
2. Family medical history -  
We did not record the family medical histories of our subjects for hypertension, 
DM2, or cancer. Offspring of DM2 patients have lower circulating ADPN levels [22] as 
compared to those without the family history of DM2. But short-term (7-weeks) aerobic 
training reported similar increases in ADPN levels in the offspring of DM2 patients and 
those without the family history of DM2 [23].  
3. Intensity of exercise training –  
VO2max is a measure of a subject’s aerobic capacity. Exercise studies also use 
VO2max as a measure of intensity of exercise training. The scope of our training protocol 
was not to improve the endurance capacity of subjects, but to train them to complete a 
full-distance marathon. Our study measured the effect of increasing duration (distance) of 
training, but not intensity of training, on changes in ADPN levels. We measured the 
intensity of aerobic training as pace (minutes taken to complete a mile distance) of the 
subject. Our subjects were instructed to follow the given training protocol and trained 
independently, hence the best estimate of the intensity of their aerobic training was 
determined by pace measurement. There were no significant differences in the pace at 
baseline and at the end of 6 mos in the trained or untrained subjects.  
4. Ethnic composition of the cohorts –  
Non-Hispanic whites (Caucasians) have higher ADPN levels compared to other 
ethnic groups, e.g. non-Hispanic blacks, Asians, and Hispanics [24]. Because our study 
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measured changes in ADPN levels in response to the long-term aerobic training, we did 
not restrict the study cohorts to a specific ethnic group. The effect of ethnicity, if any, on 
the changes in ADPN levels due to exercise (aerobic or resistance) training have not been 
noted. When we separated our subjects into two groups based on their ethnicity: 
Caucasians and other-than-Caucasians, the ratio of Caucasians to other-than-Caucasians 
was similar within each gender for the trained and untrained study cohorts. Thus, 
ethnicity was not a likely confounding factor to the results of the study.  
5. Menopausal status or day of menstrual cycle -  
Our study included premenopausal women both on and not on oral contraceptives 
and postmenopausal females both on and not on hormone replacement therapy (HRT). 
ADPN levels do not differ between pre and postmenopausal women nor between 
postmenopausal women on HRT and not on HRT [25]. We also included premenopausal 
women both on and not on oral contraceptives because ADPN levels in females are 
reported to be stable throughout the menstrual cycle implying that changes in estrogen 
levels do not affect ADPN levels [26].  
It has been noted that the luteal phase of the menstrual cycle is associated with 
weight gain in women [62]. The weight gain is anticipated due to premenstrual increases 
in appetite and eating and/or fluid retention [63]. The changes in appetite, water retention 
and the resulting weight gain is reported to be minor [27] and higher for women using 
monophasic oral contraceptives than bi or triphasic oral contraceptives [28]. We did not 
control for the menstrual phases of the premenopausal females in the study for blood 
draws and anthropometric measurements. This may account for some of the lack of 
anthropometric reductions in some premenopausal females in the study.  
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6. Age matching of the cohorts -  
We did not match individual subjects by age between comparison groups, but the 
mean ages of male and female groups from trained and untrained cohorts were similar. 
Differences in age do not affect ADPN levels in females [29-31], but aging may increase 
ADPN levels in normal-weight males over the age of 65 [32, 33]. However, males from 
both trained and untrained cohorts that completed the 6-mo study and provided the 
complete dataset were under the age of 65. Although the subjects were not age-matched, 
the numerically small mean difference between the ages of completing male and female 
groups is unlikely to significantly affect the comparability of our study groups either in 
terms of ADPN levels or changes in ADPN levels. 
7. Cohort size -  
The sample sizes of our study groups are similar to the sample sizes of other 
exercise-intervention study cohorts. But the specific reasons for the low sample size in 
our study were –  
(i) Inclusion of only middle-aged, multi-year trained or untrained running 
club members  
(ii) Exclusion of potential subjects on prescription medicines known to 
influence ADPN levels 
(iii) Program attrition/drop out –  
We experienced a lower drop out rate (36%) in untrained male subjects, than in 
untrained female subjects (77%). We know anecdotally that repetitive stress injuries 
disproportionately afflicted the untrained female subjects, but injuries did not account for 
all who withdrew. We conjecture that untrained female subjects were especially 
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motivated to train in order to lose weight and that untrained male subjects were more 
motivated to train in order to become more "fit" or "healthy". About 81% of the untrained 
females that dropped out did so by half way through the study. We speculate that when 
some of the overweight untrained females found little or no weight loss part-way into the 
training program, they lost their primary incentive for training and withdrew from the 
program.  
The drop out rate was much lower in the trained subjects (males and females = 
33.3%). The trained subjects withdrew from the study mainly due to repetitive stress 
injuries, which are common among many full-distance marathon runners during longer 
training runs [34].  
8. Pro-inflammatory adipokines –  
We did not measure pro-inflammatory cytokines, such as IL-6 or TNF- in 
addition to FPI, FPG and ADPN. Hence, we can not connect increases in ADPN levels 
observed in our study to reductions in pro-inflammatory adipokines. Out of many 
adipokines, ADPN has closest structural resemblance to TNF-. An inverse correlation 
has been reported in TNF- and ADPN levels [35]. Studies have reported a lack of 
reduction in TNF- [36] and reductions in TNF- along with increases in ADPN levels 
[37]. It is possible that increases in ADPN occur independently of reductions in other 
pro-inflammatory adipokines.  
9. Dietary control in the study –  
Dietary intervention significantly increased ADPN levels, but not by 3-mo 
aerobic exercise training in male rats [38]. The results of this study suggested that ADPN 
levels may change differently by diet and exercise intervention. We did not regulate the 
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dietary intake of our subjects. We now believe that controlling dietary intake in an 
exercise intervention study would be advisable because having a similar diet among 
subjects would help eliminate the possible influence of dietary variation on ADPN levels. 
A controlled diet in an exercise-intervention study can be achieved by: 1) recruiting 
subjects from the same baseline BMI group, e.g. overweight, obese, or normal-weight 
subjects only and keeping total caloric intake constant between the study groups or 2) If 
the cohort has a range of baseline BMI, the total number of calories can be assigned 
based on a subject’s baseline BMI and physical activity while keeping the proportion of 
major nutrients e.g. carbohydrates, proteins, fats, and fiber same in the subjects’ diet 
during the period of the study.  
10. Measurement of insulin resistance using HOMA-IR equation –  
We calculated insulin resistance using the HOMA-IR equation, which is a 
surrogate measure of insulin resistance [39]. Considering the long-term aerobic exercise 
intervention of our study, it was difficult to use the gold standard, hyperinsulinemic 
euglycemic clamp technique to measure insulin resistance of the subjects. The clamp 
procedure is invasive, laborious, requires drawing multiple blood samples and has to be 
conducted in a hospital setting. The insulin resistance values obtained by the HOMA-IR 
method correlate with those obtained from the clamp technique and HOMA-IR method is 
thus a reliable alternative to the clamp method of insulin resistance measurement [40]. 
Currently, tissue-specific insulin resistance is measured in three major organs: Liver, 
skeletal muscle, and adipose tissue. While the HOMA-IR technique is reliable, it does not 
provide information about organ-specific insulin resistance. It would be beneficial to 
know if ADPN levels in our study increased due to improvement in insulin sensitivity in 
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whole body or a specific organ. Hyperinsulinemic euglycemic clamp method in 
combination with radio-labeled glucose, allows quantification of the organ-specific 
contribution insulin resistance to the defect in whole-body insulin-mediated glucose 
disposal [41].  
 
Recommendations for Changes in Methodology 
1. Measurement of Insulin levels –  
Consider using an ELISA kit with a standard curve range similar to the physiological 
FPI range (3-20 µU/ml). Ultrasensitive assay kits such as Insulin Ultrasensitive ELISA 
(80-INSHUU-E01, Alpco Diagnostics, Salem, NH) offers the standard curve range 
similar of the physiologic range of FPI (0.15 – 20 µU/ml). We used EZHI-14K (LINCO 
Research, St. Charles, MO) ELISA kit to measure FPI levels. The standard curve of this 
assay ranges from 2 – 200 µU/ml. As a result, this kit is not sensitive to measure 
physiological FPI levels (3-20 µU/ml) in healthy subjects. Alpco Diagnostics’ 
ultrasensitive insulin kit was not available when we were conducting assays in year 2007.  
2. Measuring insulin resistance –  
Consider using the hyperinsulinemic euglycemic clamp technique to measure insulin 
sensitivity in place of a surrogate measure of insulin resistance such as the HOMA-IR 
score. Also consider employing glucose utilization technique to measure organ-specific 
insulin resistance. We could not use the glucose clamp technique, as it requires dedicated 
facility, which is not currently available at Loma Linda University. 
 
 
76 
3. Measuring body fat –  
Consider using Dual energy X-ray absorptiometry (DXA, formerly known as DEXA), 
to measure body fat. This also is beneficial for knowing body fat composition and 
changes in different body fat compartments. DXA measurements are expensive and time 
consuming. In addition, the goal of the study was not to correlate increases in ADPN 
through long-term aerobic exercise training to changes in body fat composition. Hence, 
we used the BIA (bioelectric impedance) method of measurement of body fat.  
4. Measurement of aerobic capacity –  
Consider using VO2max measurement technique in place of “pace” of a subject to 
measure the “fitness” or aerobic capacity of a subject. This measure will indicate if long-
term aerobic training improved the subject’s aerobic capacity. However, measuring 
VO2max requires an operational human performance laboratory which is not available at 
Loma Linda University. 
 
Future Studies 
 My hope is that the successes and challenges of the present research project will 
open doors in new directions to further understand the connection between exercise and 
adiponectin levels.  
1. Increase the number of time points for sample acquisition between baseline and 
the end of training protocol in a long-term aerobic training program. This will help in 
understanding if there is a dose-response relationship between increase in exercise 
training and ADPN levels.  
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2. Continue fasting sample acquisition after end of the 6-mo aerobic training 
program. This will help in understanding the time-course of changes in ADPN levels 
after training distance is significantly reduced.  
3. Acquire one-time, fasting blood samples from untrained and trained subjects and 
separate the subjects based on ethnicity in a larger cross-sectional study. This will help in 
understanding the influence of ethnicity on exercise-induced increases in ADPN levels.  
4. Conduct an exercise-intervention study with controlled dietary intake (not 
restricted). This will help in understanding if changes in ADPN are as a result of exercise 
intervention alone and not due to dietary changes that might occur during a long-term 
aerobic exercise-intervention.  
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